ReviewPublished 15 April 2026Analytical similarity as the primary determinant of monoclonal antibody development: toward evidence-efficient regulatory frameworksSarfaraz K. NiaziFrontiers in Drug Deliverydoi 10.3389/fddev.2026.1801236
ReviewPublished 26 November 2025Discrepancies in regulations in post-marketing safety surveillance of drug-device combination products in the EU and US: a reviewJoan D’souza · Mukesh Nandave · Ruth BlöchlingerFrontiers in Drug Safety and Regulationdoi 10.3389/fdsfr.2025.1609455
